In this study, CPA-7, an inhibitor of Stat3 dimerization, and STAT3 siRNA were used efficiently to reverse the immune profile of TAMs and cause tumor growth inhibition in the GL261 GBM mouse model [143]. The gene discussed is STAT3; the disease is glioblastoma.